Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Internal Medicine (Tokyo, Japan)|July 24, 2024
Successful Treatment with Ramucirumab Plus Erlotinib following Osimertinib-induced Interstitial Lung DiseaseShodai Fujimoto, Naoko Katsurada, Daisuke Hazama, et al.Oncotargets and Therapy|June 14, 2019
Novel cancer therapy targeting microbiomeTatsuya Nagano, Takehiro Otoshi, Daisuke Hazama, et al.Internal Medicine (Tokyo, Japan)|November 10, 2024
Localized Unresectable Thymic Carcinoma Treated with Induction Chemotherapy with Lenvatinib before RadiotherapyShodai Fujimoto, Naoko Katsurada, Rie Sasaki, et al.International Journal of Molecular Sciences|May 30, 2019
Crucial Role of Extracellular Vesicles in Bronchial AsthmaTatsuya Nagano, Masahiro Katsurada, Ryota Dokuni, et al.Cancer Science|February 24, 2018
Anti-human SIRPα antibody is a new tool for cancer immunotherapyYoji Murata, Daisuke Tanaka, Daisuke Hazama, et al.Scientific Reports|May 12, 2021
A novel automatic cough frequency monitoring system combining a triaxial accelerometer and a stretchable strain sensorTakehiro Otoshi, Tatsuya Nagano, Shintaro Izumi, et al.Scientific Reports|September 3, 2024
Randomized crossover trial of a demand oxygen delivery system in nocturnal hypoxemiaAtsuhiko Yatani, Tatsuya Nagano, Sae Murakami, et al.Oncotargets and Therapy|December 11, 2019
Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case-Control StudyTatsunori Kiriu, Masatsugu Yamamoto, Tatsuya Nagano, et al.Thoracic Cancer|April 16, 2024
Impact of concurrent medications on the outcome of immunotherapy in non-small cell lung carcinomaJun Yamada, Takafumi Fukui, Atsuhiko Yatani, et al.Anticancer Research|December 31, 2021
Chloride Intracellular Channel 1 Expression Is Associated With Poor Prognosis of Lung AdenocarcinomaYuichiro Yasuda, Tatsuya Nagano, Naoe Jimbo, et al.Pageof 4